Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Ueyama

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 29, 2022
Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?Hiroki Ueyama, Peter C Block
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2022
Left ventricular outflow tract calcification: Does the geometry matter?Hiroki Ueyama, Peter C Block
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 12, 2023
Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?Hiroki Ueyama, Peter C Block
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2022
Membranous septum length may not be the answerHiroki Ueyama, Peter C Block
The American Journal of Cardiology|July 2, 2021
Efficacy of Sacubitril-Valsartan in Patients With Reduced Left Ventricular Ejection FractionAlexandros Briasoulis, Toshiki Kuno, Hiroki Ueyama
American Heart Journal|July 22, 2020
P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trialsToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 22, 2021
Acute allograft rejection after heart transplantation: Outcomes of admissions and 30-day re-admissionsAlexandros Briasoulis, Hiroki Ueyama, Toshiki Kuno, et al.
Scandinavian Cardiovascular Journal : SCJ|January 10, 2022
The risk of stent thrombosis of dual antithrombotic therapy for patients who require oral anticoagulant undergoing percutaneous coronary intervention: insights of a meta-analysis of randomized trialsToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
American Heart Journal|November 29, 2020
Choosing between aspirin or P2Y12 monotherapy after short course of DAPTToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 7, 2020
Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized TrialsToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 29, 2022
Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?Hiroki Ueyama, Peter C Block
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2022
Left ventricular outflow tract calcification: Does the geometry matter?Hiroki Ueyama, Peter C Block
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 12, 2023
Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?Hiroki Ueyama, Peter C Block
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2022
Membranous septum length may not be the answerHiroki Ueyama, Peter C Block
The American Journal of Cardiology|July 2, 2021
Efficacy of Sacubitril-Valsartan in Patients With Reduced Left Ventricular Ejection FractionAlexandros Briasoulis, Toshiki Kuno, Hiroki Ueyama
American Heart Journal|July 22, 2020
P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trialsToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 22, 2021
Acute allograft rejection after heart transplantation: Outcomes of admissions and 30-day re-admissionsAlexandros Briasoulis, Hiroki Ueyama, Toshiki Kuno, et al.
Scandinavian Cardiovascular Journal : SCJ|January 10, 2022
The risk of stent thrombosis of dual antithrombotic therapy for patients who require oral anticoagulant undergoing percutaneous coronary intervention: insights of a meta-analysis of randomized trialsToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
American Heart Journal|November 29, 2020
Choosing between aspirin or P2Y12 monotherapy after short course of DAPTToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 7, 2020
Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized TrialsToshiki Kuno, Hiroki Ueyama, Hisato Takagi, et al.
Pageof 8